3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Active not recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Conditions
Breast Neoplasms
157
Carcinoma, Intraductal, Noninfiltrating
16
Breast Carcinoma In Situ
12
Neoplasm Metastasis
9
Ovarian Neoplasms
7
Breast Neoplasms, Male
7
Neoplasms
4
Prostatic Neoplasms
3
Inflammatory Breast Neoplasms
3
Glioblastoma
3
Breast Cancer Female
3
Urinary Bladder Neoplasms
2
Recurrence
2
Pancreatic Neoplasms
2
Obesity
2
Infertility
2
Hot Flashes
2
Fibroadenoma
2
Fallopian Tube Neoplasms
2
Endometrial Neoplasms
2
ER+ Breast Cancer
2
Brain Neoplasms
2
Uterine Cervical Neoplasms
1
Triple Negative Breast Neoplasms
1
Sleep Wake Disorders
1
Sexuality
1
Risk Reduction Behavior
1
Rhabdoid Tumor
1
Pyloric Stenosis, Hypertrophic
1
Primary Breast Cancer
1
Interventions
Clomiphene
10
Metformin
9
Letrozole
3
Medroxyprogesterone Acetate
2
salicylsalicylic acid
1
maltodextrin
1
Vitamin D
1
Ultrasonography
1
Tamoxifen
1
Sodium Salicylate
1
Raloxifene Hydrochloride
1
Progestins
1
Progesterone
1
Nimodipine
1
Inulin
1
Inositol
1
Hematologic Tests
1
Glycoprotein Hormones, alpha Subunit
1
Folic Acid
1
Flutamide
1
Chorionic Gonadotropin
1
Blood Specimen Collection
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Anovulation
×
Tamoxifen
×
Clear all
NCT07616973
2026-06-01
LET-CC-TAM
Sana'a University
Phase 3
Active not recruiting
240 enrolled